HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,500 | +183.7% | 88,216 | +9.7% | 0.00% | – |
| Q4 2022 | $24,145 | +201.8% | 80,403 | +361.9% | 0.00% | – |
| Q3 2022 | $8,000 | -46.7% | 17,407 | -32.1% | 0.00% | – |
| Q2 2022 | $15,000 | -68.8% | 25,640 | -31.7% | 0.00% | – |
| Q1 2022 | $48,000 | +14.3% | 37,563 | +1.1% | 0.00% | – |
| Q4 2021 | $42,000 | -22.2% | 37,141 | +6.0% | 0.00% | – |
| Q3 2021 | $54,000 | -70.0% | 35,036 | -61.5% | 0.00% | – |
| Q2 2021 | $180,000 | – | 91,106 | +197956.5% | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 46 | -99.3% | 0.00% | – |
| Q4 2020 | $14,000 | – | 6,362 | +11681.5% | 0.00% | – |
| Q3 2020 | $0 | – | 54 | -37.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 86 | -89.6% | 0.00% | – |
| Q1 2020 | $1,000 | -94.7% | 823 | -76.6% | 0.00% | – |
| Q4 2019 | $19,000 | – | 3,519 | +7231.2% | 0.00% | – |
| Q3 2019 | $0 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |